Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome
Status:
Recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of rituximab(RTX) and
mycophenolate mofetile(MMF) in the treatment of children with low-dose steroid-dependent
nephrotic syndrome(SDNS).
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Chongqing Medical University